Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Multiple Sclerosis and CYP2C9[original query] |
|---|
| Enantioselectivity in the Metabolism of Cyclophosphamide in Patients With Multiple or Systemic Sclerosis. Journal of clinical pharmacology 2017 Jan . de Castro Francine Attié, Simões Belinda Pinto, Coelho Eduardo Barbosa, Lanchote Vera Luc |
| Pharmacogenetics of siponimod: A systematic review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2022 9 153 113536. Díaz-Villamarín Xando, Piñar-Morales Raquel, Barrero-Hernández Francisco Javier, Antúnez-Rodríguez Alba, Cabeza-Barrera José, Morón-Romero Roc |
| [Siponimod (BAF312): General Characteristics and Clinical Implications of Pharmacogenomic Dosage in the Treatment of Active Secondary Progressive Multiple Sclerosis]. Revista medica de Chile 2024 8 151 (10): 1375-1384. Susan Calfunao, Matías Carrasco, Carolina Gutierrez, Leslie Cerpa, Nelson Varela, Luis Quiñon |
- Page last reviewed:Feb 1, 2024
- Content source: